% ============================================================================
% CONSTRAINT STORY: safety_risk_structure
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_safety_risk_structure, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:constraint_vindicates/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    domain_priors:emerges_naturally/1,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: safety_risk_structure
 *   human_readable: Irreducible Safety Risk Structure in Germline Genome Editing
 *   domain: bioethics/reproductive_medicine/genetic_engineering
 *
 * SUMMARY:
 *   The safety risk structure in germline genome editing describes the
 *   irreducible biological uncertainty inherent to current CRISPR-based
 *   technologies: off-target mutations (unintended edits at genomic sites
 *   with sequence similarity to the target), mosaicism (heterogeneous editing
 *   outcomes across cells in the early embryo), and pleiotropic effects
 *   (unintended phenotypic consequences of intended edits due to complex gene
 *   network interactions). This constraint is presented as a natural law — a
 *   property of the biological system rather than a social construction.
 *   However, the presence of identifiable beneficiaries (regulatory agencies
 *   whose authority is justified by the risk, bioethics consulting firms
 *   whose revenue depends on ongoing uncertainty, established research
 *   institutions whose funding flows from safety research) triggers the false
 *   summit detector. The omega variables document the irreducible
 *   uncertainties: Is this constraint a genuine natural law that will persist
 *   regardless of technological advancement, or a contingent limitation of
 *   current methods that future technologies (base editing, prime editing,
 *   improved delivery systems, better predictive models) will substantially
 *   reduce? The measurements show modest extraction accumulation (0.05 to
 *   0.08 over 15 years) and slight theater increase (0.10 to 0.15),
 *   consistent with a constraint that is primarily natural but has acquired a
 *   modest extractive overlay as institutional gatekeeping has matured.
 *
 * KEY AGENTS:
 *   - Future Generations (Edited Lineages): Primary potential victim (powerless/trapped) — cannot exit the biological consequences of germline edits; bear any realized harms from off-target mutations, mosaicism, or pleiotropic effects across generations
 *   - Prospective Parents: Moderate power (moderate/constrained) — face the constraint as a natural limit when considering germline editing for medical necessity; constrained by available alternatives and biological uncertainty
 *   - Regulatory Agencies (FDA, EMA, National Ethics Committees): Institutional beneficiary (institutional/arbitrage) — authority justified by the safety risk structure; benefit from gatekeeping function but do not create the underlying biological uncertainty
 *   - Bioethics Consulting Industry: Institutional beneficiary (institutional/arbitrage) — revenue stream depends on ongoing ethical uncertainty and regulatory complexity; benefit from the constraint's persistence
 *   - Established Research Institutions: Institutional beneficiary (institutional/arbitrage) — funding for safety research, method development, and long-term outcome studies; benefit from the constraint's existence but also work to characterize and mitigate it
 *   - International Scientific Consortia: Organized actors (organized/mobile) — coordinate governance efforts (moratoria, guidelines) in response to the constraint; see the safety risk as a natural limit requiring collective management
 *   - Analytical Observer: Civilizational view (analytical/analytical) — evaluates whether the constraint is a genuine natural law or a naturalized institutional arrangement; FSM detector flags the beneficiary structure for investigation
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(safety_risk_structure, 0.08).
domain_priors:suppression_score(safety_risk_structure, 0.12).
domain_priors:theater_ratio(safety_risk_structure, 0.15).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(safety_risk_structure, extractiveness, 0.08).
narrative_ontology:constraint_metric(safety_risk_structure, suppression_requirement, 0.12).
narrative_ontology:constraint_metric(safety_risk_structure, theater_ratio, 0.15).

% --- NL Profile Metrics (required for mountain constraints) ---
narrative_ontology:constraint_metric(safety_risk_structure, accessibility_collapse, 0.92).
narrative_ontology:constraint_metric(safety_risk_structure, resistance, 0.08).

% --- Constraint claim ---
narrative_ontology:constraint_claim(safety_risk_structure, mountain).
narrative_ontology:human_readable(safety_risk_structure, "Irreducible Safety Risk Structure in Germline Genome Editing").
narrative_ontology:topic_domain(safety_risk_structure, "bioethics/reproductive_medicine/genetic_engineering").

domain_priors:emerges_naturally(safety_risk_structure).

% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(safety_risk_structure, regulatory_agencies).
narrative_ontology:constraint_beneficiary(safety_risk_structure, bioethics_consulting_industry).
narrative_ontology:constraint_beneficiary(safety_risk_structure, established_research_institutions).
narrative_ontology:constraint_vindicates(safety_risk_structure, precautionary_principle_in_germline_intervention).
narrative_ontology:constraint_vindicates(safety_risk_structure, intergenerational_harm_prevention_doctrine).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: FUTURE GENERATIONS — Cannot exit the constraint; bear any realized harms from germline edits. The safety risk structure appears as an immutable natural law: off-target mutations, mosaicism, and pleiotropic effects are inherent to current genome editing technology. No agency to modify the constraint, no exit from the biological consequences.
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(powerless),
            time_horizon(biographical),
            exit_options(trapped),
            spatial_scope(universal))).

% PERSPECTIVE 2: PROSPECTIVE PARENTS — Constrained by medical necessity and available alternatives. The safety risk structure appears as a natural limit: the biological uncertainty about off-target effects and pleiotropic consequences is not a policy choice but a property of the technology itself. High accessibility collapse: once the mechanism is understood, no alternative pathway avoids the risk.
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(moderate),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 3: REGULATORY AGENCIES — Institutional actors with arbitrage-level exit (can choose not to regulate, can defer to international bodies). The safety risk structure appears as a natural constraint: the biological uncertainty is not created by regulation but discovered through empirical investigation. Agencies benefit from the constraint's existence (it justifies their gatekeeping function) but do not create the underlying risk.
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(institutional),
            time_horizon(generational),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 4: RESEARCH INSTITUTIONS — Benefit from the constraint through funding for safety research, ethics consultation, and method development. The safety risk structure appears as a natural limit that their research aims to characterize and mitigate. High accessibility collapse: the biological mechanisms (CRISPR off-target binding, mosaicism in early embryos, pleiotropic gene networks) are not institutional constructs.
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(institutional),
            time_horizon(generational),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 5: ORGANIZED SCIENTIFIC COMMUNITY — Organized actors with mobile exit options (can shift research focus, relocate to permissive jurisdictions). The safety risk structure appears as a natural constraint: the biological uncertainty is a property of the technology, not a social construction. The community's governance efforts (moratoria, guidelines) respond to the constraint rather than creating it.
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(organized),
            time_horizon(generational),
            exit_options(mobile),
            spatial_scope(global))).

% PERSPECTIVE 6: ANALYTICAL OBSERVER — The safety risk structure is a genuine natural law at current technological maturity: off-target mutation rates, mosaicism frequencies, and pleiotropic effects are empirical properties of CRISPR-Cas9 and related systems, not institutional constructs. The constraint's extractiveness is negligible (0.08) because the biological uncertainty exists independently of who benefits from its recognition. However, the presence of identifiable beneficiaries (regulatory agencies, bioethics consulting industry, established research institutions) triggers FSM evaluation: is this constraint a genuine natural law, or a naturalized institutional arrangement that benefits gatekeepers?
constraint_indexing:constraint_classification(safety_risk_structure, mountain,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(universal))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(safety_risk_structure_tests).

test(invariance_check) :-
    % Verify that as a Mountain, the classification is uniform across perspectives.
    constraint_indexing:constraint_classification(safety_risk_structure, TypeTarget, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(safety_risk_structure, TypeBeneficiary, context(agent_power(institutional), _, _, _)),
    TypeTarget == TypeBeneficiary,
    TypeTarget == mountain.

test(mountain_threshold_validation) :-
    config:param(extractiveness_metric_name, ExtMetricName),
    narrative_ontology:constraint_metric(safety_risk_structure, ExtMetricName, E),
    domain_priors:suppression_score(safety_risk_structure, S),
    E =< 0.25,
    S =< 0.05.

test(nl_profile_validation) :-
    domain_priors:emerges_naturally(safety_risk_structure),
    narrative_ontology:constraint_metric(safety_risk_structure, accessibility_collapse, AC),
    narrative_ontology:constraint_metric(safety_risk_structure, resistance, R),
    AC >= 0.85,
    R =< 0.15.

:- end_tests(safety_risk_structure_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.08): Very low. The biological uncertainty (off-target mutations, mosaicism, pleiotropic effects) exists independently of institutional arrangements. The modest extraction reflects that regulatory agencies, bioethics consultants, and research institutions benefit from the constraint's existence, but they do not create the underlying risk. The extraction has accumulated slightly over the interval (0.05 to 0.08) as institutional gatekeeping has matured, but remains well below the threshold for non-mountain classification. Suppression (0.12): Very low. The constraint does not suppress alternatives through coercion — it is a biological property of current technology. The modest suppression reflects regulatory barriers to experimentation, but these are responses to genuine risk rather than extractive gatekeeping. Theater ratio (0.15): Very low. Most safety research and regulatory review is functional rather than performative: off-target detection assays, mosaicism quantification, and phenotypic outcome tracking are genuine empirical investigations. The modest theater reflects some performative ethics consultation and redundant regulatory review, but the core activity is substantive. Accessibility collapse (0.92): Very high. Once the biological mechanisms are understood (CRISPR off-target binding kinetics, mosaicism from editing timing, pleiotropic gene networks), no alternative pathway avoids the risk at current technological maturity. The constraint is not a matter of choosing different methods — it is a property of editing complex genomes. Resistance (0.08): Very low. The constraint meets minimal active resistance because it is widely recognized as a genuine biological limit. Some resistance comes from researchers advocating for permissive regulation or arguing that risks are overstated, but the core constraint (biological uncertainty exists) is uncontested.
 *
 * PERSPECTIVAL GAP:
 *   All six perspectives classify this constraint as mountain, which is unusual and diagnostic. The uniformity reflects that the biological uncertainty (off-target mutations, mosaicism, pleiotropic effects) is widely recognized as a property of current technology rather than a social construction. However, the presence of identifiable beneficiaries creates a structural ambiguity: regulatory agencies, bioethics consultants, and research institutions benefit from the constraint's existence, which triggers the false summit detector. The perspectival gap is not between classification types (all see mountain) but between the genuine natural law interpretation (the biological uncertainty is irreducible) and the false summit interpretation (the constraint is a contingent technological limitation that has been naturalized to justify institutional gatekeeping). The omega variables document this ambiguity: if future technologies substantially reduce off-target rates, mosaicism, and pleiotropic unpredictability, the constraint was never a natural law — it was a temporary technological limit that beneficiaries had an incentive to present as immutable. The analytical observer's mountain classification is provisional pending resolution of the omega variables.
 *
 * DIRECTIONALITY LOGIC:
 *   Future generations are full victims (d → 1.0): they bear any realized harms from germline edits with no agency to modify the constraint and no exit from biological consequences. Prospective parents are moderate victims (d → 0.6): they face the constraint as a natural limit when considering germline editing, constrained by medical necessity and available alternatives. Regulatory agencies are beneficiaries (d → 0.2): their authority is justified by the safety risk structure, and they benefit from gatekeeping function, but they do not create the underlying biological uncertainty — the low d reflects that the benefit is secondary to a genuine natural constraint. Bioethics consulting industry are beneficiaries (d → 0.15): revenue depends on ongoing uncertainty, but the uncertainty is not manufactured — the low d reflects that the benefit is parasitic on a genuine constraint rather than extractive creation of the constraint. Research institutions are beneficiaries (d → 0.25): funding flows from safety research, but the research is substantive (low theater ratio) — the benefit is from characterizing a genuine risk, not from manufacturing uncertainty. Organized scientific community are symmetric (d → 0.5): they coordinate governance in response to the constraint but do not benefit asymmetrically from its existence. Analytical observer has no directionality (d is not applicable to analytical context).
 *
 * MANDATROPHY ANALYSIS:
 *   This constraint demonstrates the false summit detection mechanism. The claimed type is mountain, and all perspectives agree on mountain classification, but the structural data (beneficiaries present, modest extraction accumulation over time, slight theater increase) triggers FSM evaluation. The mandatrophy resolution is not 'which type is correct?' but 'is this mountain genuine or naturalized?' The omega variables provide the resolution pathway: empirical investigation of whether the safety risk is technologically contingent or biologically irreducible. If off-target rates, mosaicism, and pleiotropic unpredictability decline substantially with next-generation technologies, the constraint reclassifies to scaffold (temporary limit with sunset logic). If they remain high despite technological advancement, the constraint is confirmed as genuine mountain. The beneficiary structure (regulatory agencies, bioethics consultants, research institutions) does not prove the constraint is false summit — beneficiaries can exist for genuine natural laws — but it raises the question and justifies the omega variables. The modest extraction (0.08) and low theater (0.15) are consistent with a genuine natural law that has acquired a small extractive overlay, not with a fully naturalized institutional arrangement.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    natural_law_vs_technological_contingency,
    'Is the safety risk structure an immutable property of genome editing, or a contingent limitation of current technology that future methods (base editing, prime editing, improved delivery systems) will substantially reduce?',
    'Longitudinal tracking of off-target rates, mosaicism frequencies, and pleiotropic effects across successive generations of editing technology. If rates decline by >80% within 20 years, the constraint was technological contingency. If rates remain >50% of current levels, the constraint is closer to natural law.',
    'If technological contingency: the constraint is a temporary scaffold (current safety limits justify moratoria until better methods mature). If natural law: the constraint is a genuine mountain (germline editing faces irreducible biological limits). Classification shifts from mountain to scaffold if resolution favors contingency.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(natural_law_vs_technological_contingency, empirical, 'Whether safety risk is immutable natural law or contingent technological limit').

omega_variable(
    beneficiary_structure_ambiguity,
    'Do regulatory agencies, bioethics consultants, and established research institutions benefit from the safety risk structure''s existence (extracting rents from gatekeeping and safety research), or do they merely respond to a genuine natural constraint?',
    'Comparative analysis: jurisdictions with minimal regulation vs. jurisdictions with extensive gatekeeping. If safety outcomes are similar, gatekeeping is extractive theater. If outcomes diverge significantly, gatekeeping responds to genuine risk. Also: tracking whether safety research funding and ethics consultation revenue correlate with risk persistence or risk reduction.',
    'If extractive: the constraint is a false summit (mountain classification naturalizes institutional extraction). If responsive: the constraint is a genuine mountain (beneficiaries exist but do not create the underlying risk). FSM detector flags this for investigation.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(beneficiary_structure_ambiguity, empirical, 'Whether beneficiaries extract rents or respond to genuine natural constraint').

omega_variable(
    pleiotropy_predictability_threshold,
    'Are pleiotropic effects of on-target edits fundamentally unpredictable (gene networks too complex for current modeling), or merely under-characterized (predictable with sufficient data and computational power)?',
    'Machine learning models trained on large-scale phenotypic data from edited organisms. If prediction accuracy plateaus below 60% despite increasing data, pleiotropy is fundamentally unpredictable. If accuracy exceeds 85% with sufficient training data, pleiotropy is under-characterized but predictable.',
    'If fundamentally unpredictable: the constraint is a genuine natural law (irreducible biological complexity). If under-characterized: the constraint is a temporary knowledge gap (scaffold logic applies — predictive models will mature and reduce uncertainty).',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(pleiotropy_predictability_threshold, empirical, 'Whether pleiotropic effects are fundamentally unpredictable or merely under-characterized').

omega_variable(
    mosaicism_elimination_feasibility,
    'Can mosaicism in edited embryos be eliminated through improved delivery timing and single-cell editing, or is it an irreducible consequence of editing multi-cell embryos?',
    'Experimental trials with single-cell (zygote-stage) editing vs. multi-cell editing. If mosaicism rates drop below 5% with optimized single-cell protocols, mosaicism is a technical problem. If rates remain above 20% even with single-cell editing, mosaicism is closer to irreducible.',
    'If eliminable: the constraint is technological contingency (scaffold). If irreducible: the constraint is natural law (mountain). Mosaicism is one of the three primary observables defining this constraint''s empirical status.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(mosaicism_elimination_feasibility, empirical, 'Whether mosaicism is eliminable through improved protocols or irreducible').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(safety_risk_structure, 0, 15).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(safety_risk_theater_2010, safety_risk_structure, theater_ratio, 0, 0.1).
narrative_ontology:measurement(safety_risk_theater_2013, safety_risk_structure, theater_ratio, 3, 0.12).
narrative_ontology:measurement(safety_risk_theater_2016, safety_risk_structure, theater_ratio, 6, 0.13).
narrative_ontology:measurement(safety_risk_theater_2019, safety_risk_structure, theater_ratio, 9, 0.14).
narrative_ontology:measurement(safety_risk_theater_2022, safety_risk_structure, theater_ratio, 12, 0.15).
narrative_ontology:measurement(safety_risk_theater_2025, safety_risk_structure, theater_ratio, 15, 0.15).

% Extraction over time
narrative_ontology:measurement(safety_risk_extract_2010, safety_risk_structure, base_extractiveness, 0, 0.05).
narrative_ontology:measurement(safety_risk_extract_2013, safety_risk_structure, base_extractiveness, 3, 0.06).
narrative_ontology:measurement(safety_risk_extract_2016, safety_risk_structure, base_extractiveness, 6, 0.07).
narrative_ontology:measurement(safety_risk_extract_2019, safety_risk_structure, base_extractiveness, 9, 0.08).
narrative_ontology:measurement(safety_risk_extract_2022, safety_risk_structure, base_extractiveness, 12, 0.08).
narrative_ontology:measurement(safety_risk_extract_2025, safety_risk_structure, base_extractiveness, 15, 0.08).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(safety_risk_structure, information_standard).

% DUAL FORMULATION NOTE:
% This constraint is a standalone natural law candidate. It does not decompose into multiple observables with different epsilon values — off-target mutations, mosaicism, and pleiotropic effects are three facets of the same underlying biological uncertainty (the complexity of genome editing in early embryos). Future constraint stories about specific germline editing applications (e.g., Huntington's disease prevention, enhancement editing) would reference this constraint as a dependency.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
